Cite
LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients
MLA
Akif Altinbas, et al. “LOXL-2 and TNC-C Are Markers of Liver Fibrogenesis in HCV/HIV-, HIV- and HCV-Infected Patients.” Biomarkers in Medicine, vol. 16, Aug. 2022, pp. 839–46. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1a31dfd88384b801e56906e290609116&authtype=sso&custid=ns315887.
APA
Akif Altinbas, Jacinta A Holmes, Shadi Salloum, Anna Lidofsky, Nadia Alatrakchi, Ma Somsouk, Peter Hunt, Steven Deeks, Kara W Chew, Georg Lauer, Annie Kruger, Wenyu Lin, & Raymond T Chung. (2022). LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients. Biomarkers in Medicine, 16, 839–846.
Chicago
Akif Altinbas, Jacinta A Holmes, Shadi Salloum, Anna Lidofsky, Nadia Alatrakchi, Ma Somsouk, Peter Hunt, et al. 2022. “LOXL-2 and TNC-C Are Markers of Liver Fibrogenesis in HCV/HIV-, HIV- and HCV-Infected Patients.” Biomarkers in Medicine 16 (August): 839–46. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1a31dfd88384b801e56906e290609116&authtype=sso&custid=ns315887.